Topiramate add‐on therapy for drug‐resistant focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topiramate Add‐on Therapy for Drug‐resistant Focal Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438172/1/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients:_Cochrane_systematic_review. Accessed 26 April 2024.
Topiramate add‐on therapy for drug‐resistant focal epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/1/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients:_Cochrane_systematic_review. Accessed April 26, 2024.
Topiramate add‐on therapy for drug‐resistant focal epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/1/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients:_Cochrane_systematic_review
Topiramate Add‐on Therapy for Drug‐resistant Focal Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/1/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topiramate add‐on therapy for drug‐resistant focal epilepsy
ID - 438172
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/1/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -